payers payers-providers-must-really-listen-long-covid-patients 
Clear Arch Health
FEBRUARY 23, 2022
Given the number of factors to consider in implementing a Remote Patient Monitoring (RPM) program, it’s important to make clear the benefits that RPM can offer healthcare providers, especially when combined with a Personal Emergency Response System (PERS). . What is Remote Patient Monitoring? Aging in Place .
Clear Arch Health
MAY 18, 2023
Listen and read the full text here! Clear Arch Health is a leading provider of advanced remote patient monitoring technology, personal emergency response systems and turnkey virtual care solutions. VP of Public Policy) talking about telehealth, the end of the Public Health Emergency, and virtual care going forward.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clear Arch Health
MAY 18, 2023
Listen and read the full text here! Clear Arch Health is a leading provider of advanced remote patient monitoring technology, personal emergency response systems and turnkey virtual care solutions. VP of Public Policy) talking about telehealth, the end of the Public Health Emergency, and virtual care going forward.
Healthcare IT News - Telehealth
JULY 22, 2020
Oftentimes when people think about telemedicine, they envision a patient in a clinic with a technological setup they address, with physicians on the other end at another clinic far away doing the same. So that model does not work, because that is really just remote patient care. COVID-19 changed everything.
Healthcare IT Today
JANUARY 12, 2023
Price Transparency: In 2022, we saw CMS’s Transparency in Coverage rule go into effect, requiring health plans and providers to publish their rates for care to the public. 4) Data Personalization: In 2023, we’ll see a greater shift toward prioritizing consumer needs and preferences when providing care options and provider information.
Insulin Nation
MAY 28, 2020
Research from the University of Pittsburgh provided evidence that the net price of insulin in the United States had also soared – by 51% between 2008-2017. “Today, the biggest payer for medicines — the United States government — is legally prohibited from negotiating for the price of medicines with manufacturers.
Expert insights. Personalized for you.
52 
Let's personalize your content